ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

Jack Pursey is an Evergreen Editor from England who began working at Game Rant as a List Writer in August 2020. Jack enjoys games from a wide range of genres but has a soft spot for puzzle and ...

If you hadn't heard, the Battlefield 6 battle royale mode is real, it's called RedSec, and it's expected to kick off today, October 28. Yes, it's come around that quickly, and while some questions ...

VisionWave is an early-stage defense tech firm integrating AI into autonomous vehicles, with promising technology but no revenue yet. Recent $50M equity line provides capital for proof-of-concept ...

Recently, Chinese PV mounting supplier Mibet released a new flexible mounting system designed for large-span and complex terrain applications, which has been successfully deployed at a wastewater ...

AutoFlight today announced the delivery of the world’s first electric vertical take-off and landing (eVTOL) aircraft exceeding one-ton maximum take-off weight to achieve complete airworthiness ...

You don’t have to break the bank to look like money. While doing some online shopping I came across some sneakers on Amazon that looked almost identical to low-top Chuck Taylor’s. With canvas uppers ...

Although I’m a proud sneakerhead every Fall I add a pair of crisp 6-inch wheat Timbs to my footwear rotation. It’s part of my seasonal swag schedule and it’s not something I’ve thought about changing.

SCHEELS Camo V2 isn’t just another entry into the crowded field of camouflage—it’s a redefining pivot. V2 is a camouflage pattern that prowls the edge of science and instinct, where algorithmic ...

Kia America is leaning into the summer vibe, with an effort showing how the 2026 Kia Sportage is roadtrip-ready. A two-part nationwide creative campaign, “Keep the Adventure Going," is set to the tune ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.